Investigation Report on China Olmesartan Market, 2009-2018

Published: March 2014
No. of Pages: 40
  

According to statistics from WHO, onethird of the world's adults have high blood pressure. Death toll of this disease equals to half of the total number caused by stroke and heart attack.

Angiotensin II receptor antagonist (ABR) is an important product among various antihypertensive drugs. Developed by Sankyo and Forest Laboratories, olmesartan medoxomil was approved to the U.S.A. in April 2002 with the trade name "Benicar" and was approved to Europe in October 2002. In July 2006, it was launched in Chinese market. Olmesartan can take effect very soon with low dosage, and it has strong and lasting antihypertensive effect with few adverse reactions, especially dry cough. Also because of its excellent performance worldwide, many Chinese manufacturers applied to produce the generic drug. However, this behavior caused the noted "composition patent" olmesartan patent infringement case in 2006, resulting in the "Bolar Exception" in Chinese patent system. Although Beijing Winsunny Pharmaceutical Co., Ltd. won the trial and was approved to produce the genetic drug in 2007, they violates Sankyo's patent every time they produce or sell the product. For Beijing Winsunny Pharmaceutical Co., Ltd., it has won the trial but not the market. Competition pattern of olmesartan medoxomil manufacturers from Menet indicates that olmesartan medoxomil produced by Beijing Winsunny Pharmaceutical Co., Ltd. could not go on the market until patent ZL.97126347.7 expired in 2011. As a result, market share of Beijing Winsunny Pharmaceutical Co., Ltd. is extremely low.

Statistics shows that there are more than 260 million hypertensive patients in China. According to CRI, over CNY 40 billion is annually spent on hypertension treatment. Market size of hypertensive prescription drugs exceeded CNY 20 billion in 2013 which indicates huge growth potential.

The CAGR of sales value of olmesartan in Chinese sample hospital market was more than 140% from 2007 to 2010. Based on the sales revenue, most market share is occupied by Shanghai Sankyo Pharmaceutical Co., Ltd. (founded in November 1999 by Sankyo Co., Ltd. and Zhangjiang HiTech Park Development Co., Ltd.) while other market share is seized by generic drugs from Chinese manufacturers such as Beijing Winsunny Pharmaceutical Co., Ltd.

Because of improving living standard and changing lifestyle, incidence of hypertension is estimated to grow in the next few years. As Chinese people's incomes increase, the affordability of antihypertensive drugs increases. Estimation shows that the market size of olmesartan in China will keep increasing in the next few years.

Through this report, the readers can acquire the following information:

  • Market Share of Olmesartan Produced by Different Enterprises in China Hospital Market
  • Sales Price of Olmesartan in China Hospital Market
  • Major Olmesartan Enterprises in China
  • Share of Olmesartan in Different Dosage Forms in China Hospital Market
  • Prospect of China Olmesartan Market

The Following Enterprises and People Are Recommended to Purchase This Report:

  • Antihypertensive APIs and Finished Product Manufacturers
  • Investors Focusing on China Antihypertensive Drug Market
  • Research Institutes Focusing on Drug Patent in China

Investigation Report on China Olmesartan Market, 2009-2018

Table of Contents

1 Relevant Concepts of Olmesartan
1.1 Development Process
1.2 Indication
1.3 Sales Status on the Global Market

2 Market Overview of Olmesartan in China, 2009-2013
2.1 Patent Status and "Bolar Exception" in Chinese Patent System
2.2 Major Manufacturers
2.3 Market Size

3 Investigation on Sales Value of Olmesartan in China, 2009-2013
3.1 Total Sales Value
3.2 Sales Value by Region

4 Investigation on Market Share of Major Olmesartan Manufacturers in China, 2009-2013
4.1 Market Share by Sales Value
4.2 Market Share by Sales Volume

5 Investigation on Market Size of Olmesartan by Dosage Form in China, 2009-2013
5.1 Market Share by Sales Value and Dosage Form
5.2 Market Share by Sales Volume and Dosage Form

6 Reference Price of Olmesartan Produced by Different Enterprises in China Hospital Market
6.1 Shanghai Sankyo Pharmaceutical Co., Ltd.
6.2 Beijing Winsunny Pharmaceutical Co., Ltd.
6.3 Shanghai Sine Promod Pharmaceutical Co., Ltd.

7 Analysis on Major Olmesartan Manufacturers in China, 2009-2014
7.1 Shanghai Sankyo Pharmaceutical Co., Ltd.
7.2 Beijing Winsunny Pharmaceutical Co., Ltd.
7.3 Shanghai Sine Promod Pharmaceutical Co., Ltd.

8 Prospect of China Olmesartan Market, 2014-2018
8.1 Trend of Hypertension Incidence in China
8.2 Forecast on Market Size
8.3 Forecast on Competition Pattern

List of Charts

Chart Olmesartan Products Approved to Market in China by 2014
Chart Sales Value of Olmesartan in Global Market, 2009-2013
Chart Sales Value of Olmesartan in China Hospital Market, 2009-2013
Chart Sales Value of Olmesartan by Region in China, 2009-2013
Chart Market Share of Olmesartan Enterprises by Sales Value in China, 2009-2013
Chart Price of Olmesartan Produced by Shanghai Sankyo Pharmaceutical Co., Ltd. in China Hospital Market, 2014
Chart Price of Olmesartan Produced by Beijing Winsunny Pharmaceutical Co., Ltd. in China Hospital Market, 2014
Chart Forecast on Market Size of Hospital-use Olmesartan in China, 2014-2018

Published By: China Research and Intelligence
Product Code: China Research and Intelligence1296


Did you find what you are/were looking for ? If not, read below and browse through other relevant pages for similar market research reports OR get in touch with us through the form/contact info in your right navigation panel and we’ll share relevant market report titles for you to explore.

Related Reports:

  • Plastic Resin Markets in China (16 Full Research Reports Collection)

    China's demand for plastic resin markets has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This is a collection of 17 full market research reports:158 Acrylonitri...

  • General Chemicals Markets in China Part II (Choice of Any 20 Full Research Reports from Our 200 Chemical Report Collection)

    China's demand for general chemicals markets (Part II) has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This is a choice of any 20 full market research reports:

  • Market Research of BCAAs in China

    BCAAs (Branched-Chain Amino Acids), as one kind of amino acids with high value-added, are widely used as the dietary supplement among the people involved in bodybuilding and athletics, as they can promote human muscle anabolism. BCAAs include thre...

  • Survey of Bio-pesticide Industry in China 2nd Edition

    Bio-pesticides are certain types of pesticides derived from such natural materials as animals, plants, bacteria, and certain minerals. For example, canola oil and baking soda have pesticidal applications and are considered bio-pesticides. With peo...

  • China Titanium Dioxide Opportunity

    With the fast development of TiO2 industry, China has not only become the biggest TiO2 producer and consumption market worldwide, but also has become a net exporter since 2011. It means that China is now one of the important suppliers to the world...

  • Outlook for China Glyphosate Industry 2012-2016 edition (7)

    Glyphosate, a broad-spectrum non-selective herbicide widely used to kill unwanted plants both in agricultural and in nonagricultural landscapes, has been in a leading position in the world’s herbicides in the past few years. It is estimated ...

  • BCAAs Research in China

    BCAAs (Branched Chain Amino Acid), as one kind of amino acids with high added value, are widely used as the dietary supplement among the people involved in bodybuilding and athletics because BCAAs can promote human muscle anabolism. Despite the do...

  • General Chemicals Markets in China Part V (Choice of Any 30 Full Research Reports from Our 200 Chemical Report Collection)

    China's demand for general chemicals markets (Part V) has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This is a choice of any 30 full market research reports from our 200 chemica

  • Glyphosate Competitiveness Analysis in China

    Glyphosate, a broad-spectrum herbicide, widely used to kill unwanted plants both in agriculture and in nonagricultural landscapes, has been in a leading position of herbicides in the world in the past few years; it is estimated that the glo...

  • The Future of Glyphosate Industry in China

    Glyphosate, a broad-spectrum herbicide, widely used to kill unwanted plants both in agriculture and in nonagricultural landscapes, has been in a leading position of herbicides in the world in the past few years; it is estimated that the glo...


Why ReportsnReports.com?

  • 400,000 market research reports and growing.
  • Top Fortune 500 Organizations trust us for research data.
  • 24/7 support on call as well as emails.
  • Your Details are safe with us.
  • Free support for your research requirements.
  • Report Delivery: Email
  • Delivery Time:
    • Upto 24 hrs - working days
    • Upto 48 hrs max - weekends and public holidays

Research Support / Custom Research

If this business study does not have the data and information analysis you need, contact us with your research requirements. We explore available market research reports to map your needs and share report titles with you. Alternatively, we can also offer custom research that suits your budget and timelines. Share your information requirements here.
Connect With Us
Email: sales@reportsandreports.com Call : + 1 888 391 5441

Subscription Option

Using our subscription option, you get access to market research reports and industry data of Pharmaceuticals market as per your needs. Get the best of Pharmaceuticals research reports by utilizing your research budgets in an optimum way.

More about our Subscription option
Email Alerts

Get Email alerts about market research reports from industries and publishers of your interest:

Live Chat
Live Chat by Comm100